UNSPSC 51321700: Antihyperlipidemic and hypocholesterolemic fatty acids

Antihyperlipidemic and hypocholesterolemic drugs organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid.

UNSPSC 51321700 Antihyperlipidemic and hypocholesterolemic fatty acids is a Class code covering prescription and over-the-counter pharmaceutical products that state and local governments procure for emergency medical services, public health agencies, and cooperative purchasing consortia. Recent opportunities show a broader scope than the code name suggests: state and local buyers are soliciting emergency life-support medications (including vasopressors, antiarrhythmics, and beta-blockers), generic pharmaceuticals through multistate cooperative agreements, and exploring direct-to-manufacturer prescription fulfillment models. Issuing bodies include city fire departments (Tampa Fire Rescue via the City of Tampa Purchasing Department), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP, serving Minnesota, Oregon, and participating jurisdictions). Solicitations are structured as sealed competitive bids (IFB), requests for information (RFI), and requests for proposal (RFP), with set-aside provisions for small local business enterprises where applicable.

Activity concentrates in Florida, Texas, and Minnesota, with the MMCAP cooperative extending geographic reach across multiple states including Oregon. Representative opportunities include the City of Tampa's IFB (Bid No. 26-P-00188, due April 8, 2026, estimated contract value $40,000) for four Advanced Life Support Medications line items with nine-month expiration requirements and one-year primary term plus renewal options; the Texas HHS Commission's RFI (HHS0017013, response deadline April 3, 2026) exploring direct-to-manufacturer pharmaceutical distribution models outside traditional pharmacy benefit manager and group purchasing organization channels; and MMCAP's RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers with a July 1, 2026 effective date and two-year primary term. Vendors pursuing these opportunities should expect requirements for current Good Manufacturing Practices (cGMP) certification, Drug Supply Chain Security Act (DSCSA) compliance, comprehensive insurance (commercial general liability of $2,000,000 to $5,000,000), safety data sheets compliant with OSHA Hazard Communication Standards, and pricing submissions in electronic format with specified product identifiers (NDC codes, SKUs, UPCs).